Gland Pharma Limited has informed the Exchange about Link of Recording
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges that the audio recording of its Q2 FY26 and H1 FY26 earnings call, held on November 3, 2025, has been uploaded to the company's website. The filing is a routine compliance disclosure under SEBI's Listing Regulations, made by the Company Secretary. It references an earlier disclosure dated October 17, 2025, likely the intimation of the earnings call schedule. No new financial figures, guidance, or strategic commentary is included in this filing — only the weblink to the recording.
This is a standard regulatory disclosure with no direct impact on the stock price. Investors interested in management's commentary on Q2 FY26 results should listen to the linked audio recording for potential insights on performance and outlook.